Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Background & aimsIn this nationwide study from the Israeli Inflammatory Bowel Disease Research Nucleus, we aimed to describe the incidence of very early onset inflammatory bowel diseases (VEOIBDs) with a focus on infantile-onset disease and to compare management and disease course with older children.MethodsData were retrieved from the 4 Israeli Health Maintenance Organizations covering 98% of the population. Pediatric-onset IBD was categorized as follows: adolescent onset (10 to <18 y), early onset (6 to <10 y), VEOIBD (0 to <6 y), toddler onset (2 to <6 y), and infantile onset (<2 y).ResultsA total of 5243 children with 35,469 person-years of follow-up evaluation, were diagnosed with IBD during 2005 to 2020: 4444 (85%) with adolescent onset, 548 (10%) with early onset, and 251 (4.8%) with VEOIBD, of whom 81 (1.5%) had infantile onset. The incidence of pediatric-onset IBD increased from 10.8 per 100,000 in 2005 to 15.3 per 100,000 in 2019 (average annual percentage change, 2.8%; 95% CI, 2.2%-3.4%), but that of VEOIBD remained stable (average annual percentage change, 0%; 95% CI, -2.5% to 2.6%). The infantile-onset and toddler-onset groups were treated less often with biologics (36% and 35%, respectively) vs the early onset (57%) and adolescent-onset groups (53%; P < .001). The time to steroid dependency was shorter in infantile-onset (hazard ratio [HR], 2.1; 95% CI, 1.5-2.9) and toddler-onset disease (HR, 1.6; 95% CI, 1.2-2.0) vs early onset and adolescent-onset disease, but time to hospitalizations, time to surgery, and growth delay were worse only in infantile-onset disease. In a multivariable model, infantile-onset patients had a higher risk for surgery (HR, 1.4; 95% CI, 1.1-1.9) and hospitalization (HR, 1.7; 95% CI, 1.2-2.4) than the toddler-onset group.ConclusionsThe incidence of VEOIBD remained stable. Infantile-onset IBD had worse outcomes than older children, while toddler onset had mostly similar outcomes, despite less frequent use of biologics.

More information Original publication

DOI

10.1016/j.cgh.2022.10.026

Type

Journal article

Publication Date

2023-09-01T00:00:00+00:00

Volume

21

Pages

2639 - 2648.e6

Addresses

J, u, l, i, e, t, , K, e, i, d, a, n, , I, n, s, t, i, t, u, t, e, , o, f, , P, e, d, i, a, t, r, i, c, , G, a, s, t, r, o, e, n, t, e, r, o, l, o, g, y, , H, e, p, a, t, o, l, o, g, y, , a, n, d, , N, u, t, r, i, t, i, o, n, ,, , S, h, a, a, r, e, , Z, e, d, e, k, , M, e, d, i, c, a, l, , C, e, n, t, e, r, ,, , T, h, e, , H, e, b, r, e, w, , U, n, i, v, e, r, s, i, t, y, , o, f, , J, e, r, u, s, a, l, e, m, ,, , J, e, r, u, s, a, l, e, m, ,, , I, s, r, a, e, l, .

Keywords

Intestines, Humans, Colitis, Ulcerative, Inflammatory Bowel Diseases, Crohn Disease, Biological Products, Incidence, Adolescent, Child